ExoDx Active Surveillance (Prostate Cancer) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about a medical technology called the ExoDx Prostate test. We want to find out if these test results can help us evaluate the risk of prostate cancer for patients and make better informed clinical decisions.
What is the Condition Being Studied?
Prostate Cancer
Who Can Participate in the Study?
Men ages 45+ who:
- Have low-intermediate risk prostate cancer
- Are on active surveillance
- Are scheduled for their second (confirmatory) biopsy
For more information, contact the study team at shawna.pochan@duke.edu.
Age Group
Adults
What is Involved?
If you choose to join this study, we will ask you to provide a urine sample before you have your scheduled biopsy.
Study Details
Full Title
Evaluation of ExoDx Prostate in Men with Prostate Cancer in an Active
Surveillance Regimen- A Prospective Trial
Principal Investigator
Urologic Oncologist
Protocol Number
IRB:
PRO00111203
NCT:
NCT05572099
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment